Novo Nordisk A/S (VIE:NNO2)

Novo Nordisk Statistics

Total Valuation

Novo Nordisk has a market cap or net worth of EUR 204.05 billion. The enterprise value is 214.81 billion.

Market Cap	204.05B
Enterprise Value	214.81B

Important Dates

The next estimated earnings date is Wednesday, November 5, 2025.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	Aug 15, 2025

Share Statistics

Current Share Class	3.37B
Shares Outstanding	n/a
Shares Change (YoY)	-0.57%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	0.02%
Owned by Institutions (%)	29.88%
Float	3.19B

Valuation Ratios

The trailing PE ratio is 13.70 and the forward PE ratio is 14.87.

PE Ratio	13.70
Forward PE	14.87
PS Ratio	4.88
PB Ratio	9.06
P/TBV Ratio	25.29
P/FCF Ratio	23.34
P/OCF Ratio	12.53
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.98, with an EV/FCF ratio of 24.57.

EV / Earnings	14.43
EV / Sales	5.14
EV / EBITDA	9.98
EV / EBIT	10.80
EV / FCF	24.57

Financial Position

The company has a current ratio of 0.78, with a Debt / Equity ratio of 0.59.

Current Ratio	0.78
Quick Ratio	0.50
Debt / Equity	0.59
Debt / EBITDA	0.62
Debt / FCF	1.52
Interest Coverage	17.27

Financial Efficiency

Return on equity (ROE) is 79.17% and return on invested capital (ROIC) is 42.53%.

Return on Equity (ROE)	79.17%
Return on Assets (ROA)	21.82%
Return on Invested Capital (ROIC)	42.53%
Return on Capital Employed (ROCE)	54.12%
Revenue Per Employee	533,459
Profits Per Employee	189,942
Employee Count	77,349
Asset Turnover	0.73
Inventory Turnover	1.20

Taxes

In the past 12 months, Novo Nordisk has paid 3.98 billion in taxes.

Income Tax	3.98B
Effective Tax Rate	21.10%

Stock Price Statistics

The stock price has decreased by -57.40% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-57.40%
50-Day Moving Average	48.12
200-Day Moving Average	60.87
Relative Strength Index (RSI)	42.78
Average Volume (20 Days)	12,010

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novo Nordisk had revenue of EUR 41.82 billion and earned 14.89 billion in profits. Earnings per share was 3.35.

Revenue	41.82B
Gross Profit	35.23B
Operating Income	19.93B
Pretax Income	18.87B
Net Income	14.89B
EBITDA	21.35B
EBIT	19.93B
Earnings Per Share (EPS)	3.35

Balance Sheet

The company has 2.54 billion in cash and 13.31 billion in debt, giving a net cash position of -10.77 billion.

Cash & Cash Equivalents	2.54B
Total Debt	13.31B
Net Cash	-10.77B
Net Cash Per Share	n/a
Equity (Book Value)	22.53B
Book Value Per Share	5.07
Working Capital	-6.01B

Cash Flow

In the last 12 months, operating cash flow was 16.29 billion and capital expenditures -7.55 billion, giving a free cash flow of 8.74 billion.

Operating Cash Flow	16.29B
Capital Expenditures	-7.55B
Free Cash Flow	8.74B
FCF Per Share	n/a

Margins

Gross margin is 84.26%, with operating and profit margins of 47.65% and 35.61%.

Gross Margin	84.26%
Operating Margin	47.65%
Pretax Margin	45.13%
Profit Margin	35.61%
EBITDA Margin	51.06%
EBIT Margin	47.65%
FCF Margin	20.91%

Dividends & Yields

This stock pays an annual dividend of 1.56, which amounts to a dividend yield of 3.45%.

Dividend Per Share	1.56
Dividend Yield	3.45%
Dividend Growth (YoY)	17.65%
Years of Dividend Growth	7
Payout Ratio	45.63%
Buyback Yield	0.57%
Shareholder Yield	4.02%
Earnings Yield	7.30%
FCF Yield	4.28%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on September 13, 2023. It was a forward split with a ratio of 2.

Last Split Date	Sep 13, 2023
Split Type	Forward
Split Ratio	2

Scores

Novo Nordisk has an Altman Z-Score of 7.82 and a Piotroski F-Score of 4.

Altman Z-Score	7.82
Piotroski F-Score	4